NORTH CENTRAL BRONX
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $708K
- Transactions
- 125
- Companies
- 13
- Average per transaction
- $5,664
Who reported the payments
| Regeneron | $270,036 |
| Novartis | $175,873 |
| Aesculap, Inc. | $115,979 |
| Sanofi US Services Inc. | $54,400 |
| Global Blood Therapeutics, Inc. | $45,944 |
| Bio-rad Laboratories, Inc. | $25,058 |
| E.r. Squibb & Sons, L.L.C. | $10,000 |
| Arjo Inc. | $7,500 |
| Stryker | $1,756 |
| GE HealthCare | $699 |
| Medline Industries LP | $539 |
| Encision Inc | $159 |
| Portola Pharmaceuticals, LLC | $5 |